Added to YB: 2025-02-28
Pitch date: 2025-02-26
ROVI.MC [neutral]
Laboratorios Farmaceuticos Rovi, S.A.
+16.01%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
Market Cap
EUR 3.3B
Pitch Price
EUR 53.66
Price Target
N/A
Dividend
1.45%
EV/EBITDA
16.88
P/E
24.87
EV/Sales
4.52
Sector
Pharmaceuticals
Category
turnaround
CDMOs, trading platforms and food delivery - ROVI.MC
ROVI.MC (overview): Q4 beat post-warning est. despite CDMO decline. Becat rebounded, Okedi growing. Profitability hit by CDMO & one-offs. 2025 guidance: mid-single-digit sales decline. Potential upside from vaccination changes or new CDMO clients. Near-term muted, but long-term growth potential intact.
Read full article (1 min)